$2.33
-0.08-3.53%
At close: -
$2.34
0.010.65%
After Hours: Jan 16, 5:47 PM EDT
Comments
Loading...
Lixte Biotechnology (LIXT) Forecast
NewsEarningsLixte Biotechnology (LIXT) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestLixte Biotechnology (NASDAQ:LIXT) Stock Quotes, Forecast and News Summary
Lixte Biotechnology Stock (NASDAQ: LIXT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Lixte Biotechnology (LIXT) stock?
You can purchase shares of Lixte Biotechnology (NASDAQ:LIXT) through any online brokerage.
Who are Lixte Biotechnology (LIXT) competitors?
Other companies in Lixte Biotechnology’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Vincerx Pharma (NASDAQ:VINC), Alzamend Neuro (NASDAQ:ALZN), Galecto (NASDAQ:GLTO) and Tharimmune (NASDAQ:THAR).
What is the forecast, or price target, for Lixte Biotechnology (LIXT) stock?
There is no analysis for Lixte Biotechnology to provide a consensus price target.
What is the current price for Lixte Biotechnology (LIXT)?
The stock price for Lixte Biotechnology (NASDAQ: LIXT) is $2.34 last updated January 16, 2025 at 5:47 PM EST.
Does Lixte Biotechnology (LIXT) pay a dividend?
There are no upcoming dividends for Lixte Biotechnology.
When is Lixte Biotechnology (NASDAQ:LIXT) reporting earnings?
Lixte Biotechnology’s Q4 earnings are confirmed for Tuesday, March 18, 2025.
Is Lixte Biotechnology (LIXT) going to split?
There is no upcoming split for Lixte Biotechnology.
What sector and industry does Lixte Biotechnology (LIXT) operate in?
Lixte Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.